Abstract
Sulfadimethoxine is metabolized byO-dealkylation, N4-acetylation and N1-glucuronidation. In man, only N1-glucuronidation and N4-acetylation takes place, leading to the final double conjugate N4-acetylsulfadimethoxine-N1-glucuronide. The N1-glucuronides are directly measured by high pressure liquid chromatography. When N4-acetylsulfadimethoxine is administered as parent drug, 30% of the dose is N1-glucuronidated and excreted. Fast acetylators show a shorter half-life for sulfadimethoxine than slow acetylators (27.8±4.2 h versus 36.3±5.4 h; P=0.013), similarly the half-life of the N4-acetyl conjugate is also shorter in fast acetylators (41.3±5.2 h versus 53.5±8.5 h, P=0.036). No measurable plasma concentrations of the N1-glucuronides from sulfadimethoxine are found in plasma. N1-glucuronidation results in a 75% decrease in protein binding of sulfadimethoxine. N4-acetylsulfadimethoxine and its N1-glucuronide showed the same high protein binding of 99%. Approximately 50–60% of the oral dose of sulfadimethoxine is excreted in the urine, leaving 40–50% for excretion into bile and faeces.
Similar content being viewed by others
References
Vree TB, Reekers-Ketting JJ, Hekster YA, Nouws JFM. Acetylation and deacetylation of sulphonamides in dogs. J Vet Pharmacol Ther 1983;6:153–6.
Baggot D. Pharmacokinetics of sulfadimethoxine in cats. Aust J Exp Biol Med Sci 1977;55:663–70.
Bajwa RS, Singh J. Studies on the levels of sulphadimethoxine and sulphamethoxypyridazine in blood of poultry. Ind J Animal Sci 1977;47:549–53.
Onodera T, Inoue S, Kasahara A, Oshima Y. Experimental studies on sulfadimethoxine in fowls. Jpn J Vet Sci 1970;32:275–83.
Oshima Y, Kasahara A, Onodera M. Experimental studies on sulfadimethoxine in fowls. Plasma concentration in hens after oral administration. Jpn J Vet Sci 1964;26:115–20.
Caldwell J, Williams RT, Bassir O, French MR. Drug metabolism in exotic animals. Eur J Drug Metab Pharmacokinet 1978;2:67–71.
French MR, Bababunmi EA, Golding RR, et al. The conjugation of phenol, benzoic acid, 1-naphthylacetic acid and sulphadimethoxine in the lion, civet and genet. FEBS Lett 1974;46:134–7.
Barron MG, Gedutis C, James MO. Pharmacokinetics of sulphadimethoxine in the lobsterHomarus americanus following intrapericardial administration. Xenobiotica 1988;18:269–76.
Shimoda M, Vree TB, Beneken Kolmer EWJ, Arts ThHM. The role of plasma protein binding on the metabolism and renal excretion of sulfadimethoxine and its metabolite N4-acetylsulfadimethoxine in pigs. Vet Quart (in press).
Adamson RH, Bridges JW, Kibby MR, Walker SR, Williams RT. The fate of sulphadimethoxine in primates compared with other species. Biochem J 1970;118:41–5.
Boxenbaum HG, Pellig J, Hanson LJ, Snyder WE, Kaplan SA. Pharmacokinetics of sulphadimethoxine in cattle. Res Vet Sci 1977;23:24–8.
Vree TB, Hekster YA, Tijhuis MW, Baakman M, Oosterbaan MJM, Termond EFS. Effects of methoxy groups in the N1-substituent of sulfonamides on the pathways of elimination in man. Pharm Weekbl [Sci] 1984;6:150–6.
Vree TB, Hekster YA. Clinical pharmacokinetics of sulfonamides and their metabolites. Antibiot Chemother 1987;37:25–30.
Nouws JFM, Firth EC, Vree TB, Baakman M. Pharmacokinetics and renal clearance of sulfamethazine, sulfamerazine and sulfadiazine and their N4-acetyl and hydroxy metabolites in horses. Am J Vet Res 1987;48:392–402.
Nouws JFM, Mevius D, Vree TB, Degen M. Pharmacokinetics and renal clearance of sulphadimidine, sulphamerazine and sulfadiazine and their N4-acetyl and hydroxy metabolites in pigs. Vet Quart 1989;11:78–87.
Vree TB, Hekster YA. Clinical pharmacokinetics of sulfonamides. Revisited. Antibiot Chemother 1985;34:1–200.
Vree TB, Hekster YA, Nouws JFM, Baakman M. Pharmacokinetics, metabolism and renal excretion of sulfadimidine and its N4-acetyl and hydroxy metabolites in man. Ther Drug Monit 1986;8:434–9.
Vree TB, Vree JB, Beneken Kolmer N, et al.O-Demethylation and N4-acetylation of sulfadimethoxine by the turtlePseudemys scripta elegans. Vet Quart 1989;11:138–43.
Vree TB, Vree JB, Beneken Kolmer N, et al.O-Demethylation and N4-acetylation of sulfadimethoxine by the snailCepaea hortensis. Jpn J Vet Sci 1989;51:364–8.
Bridges JW, Kibby MR, Walker SR, Williams RT. Species differences in the metabolism of sulphadimethoxine. Biochem J 1968;109:851–6.
Uno T, Kushima T, Fujimoto M. Studies on the metabolism of sulfadimethoxine. I. On the excreted substance in the human urine after oral administration of sulfadimethoxine. Chem Pharm Bull 1965;13:261–7.
Uno T, Kushima T, Hiraoka T. Studies on the metabolism of sulfadimethoxine. II. Determinations of metabolites in human and rabbit urine after oral administration of sulfadimethoxine. Chem Pharm Bull 1967;15:1272–6.
Walker SR, Williams RT. The metabolism of sulphadimethoxypyrimidine. Xenobiotica 1972;2:69–75.
Vree TB, Beneken Kolmer EWJ, Martea M, Bosch R. High performance liquid chromatography of sulfadimethoxine and its N1-glucuronide, N4-acetyl-, and N4-acetyl-N1-glucuronide metabolites in plasma and urine of man. J Chromatogr 1990;526:119–28.
Anonymous. SAS user's guide. Basics 1982 edition. Cary: SAS Institute Inc., 1982.
Veng-Pedersen P. A simple method for obtaining the mean residence time of metabolites in the body. J Pharm Sci 1986;75:818–9.
Takahashi Y. Mechanisms of nonlinear pharmacokinetics of sulfadimethoxine in cocks. Jpn J Vet 1986;48:105–9.
Takahashi Y. Identification of desmethyl metabolite of sulfadimethoxine in chicken excreta. Jpn J Vet Sci 1986;48:999–1002.
Bridges JW, Kibby MR, Williams RT. The structure of the glucuronide of sulphadimethoxine formed in man. Biochem J 1965;96:829–36.
Skachilova SY, Shramova ZI, Voronin VG, Petrugova NP, Ovchinnikova AM, Sheinker YN. Study of the conditions of the formation of impurities in technical sulfadimethoxine. Khimiko Farmatsevticheskii Zhurnal 1987;21:481–4.
Caldwell J. The significance of phase II (conjugation) reactions in drug disposition and toxicity. Life Sci 1979;24:571–8.
Ahmad B, Powell JW. N1-Glucosides as urinary metabolites of sulphadimidine, sulphamerazine and sulphamethoxazole. Eur J Drug Metab Pharmacokinet 1988;13:177–83.
Hirom PC, Millburn P, Smith RL, Williams RT. Molecular weight and chemical structure as factors in the biliary excretion of sulphonamides in the rat. Xenobiotica 1972;2:205–14.
Yagi N, Agata I, Kawamura T, et al. Fundamental pharmacokinetic behavior of sulfadimethoxine, sulfamethoxazole and their biotransformed products in dogs. Chem Pharm Bull 1981;29:3741–7.
Van Ginneken CAM, Russel FGM. Saturable pharmacokinetics in the renal excretion of drugs. Clin Pharmacokinet 1989;16:38–54.
Hubbard JW, Briggs CJ, Savage C, Smith D. Binding of sulfadimethoxine to isolated human blood protein fractions. J Pharm Sci 1984;73:1319–22.
Rieder J. Physikalisch-chemische und biologische Untersuchungen an Sulfonamiden. Arzneimittelforsch 1963;13:84–9.
Arita T, Hori R, Takada M, Misawa A. Transformation and excretion of drugs in biological systems. V. Correlation between renal excretion and biotransformation of sulfadimethoxine. Chem Pharm Bull 1971;19:930–6.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vree, T.B., Beneken Kolmer, E.W.J., Martea, M. et al. Pharmacokinetics, N1-glucuronidation and N4-acetylation of sulfadimethoxine in man. Pharmaceutisch Weekblad Scientific Edition 12, 51–59 (1990). https://doi.org/10.1007/BF01970146
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01970146